Back

Pre-existing cardiovascular diseases in large b-cell lymphoma

19 June 2026 (08:30 - 17:30)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Stratification, Prevention and Monitoring CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Tania-Mihaela Nicolaescu

Uppsala University, Sweden, Vasteras (Sweden)

45 More presentations in this session

Presentation thumbnail
Exploring lipoprotein(a) and incident heart failure in cancer patients with anthracycline-associated neoplasms
Mrs A. Stephanus (Brasilia, BR)
Abstract Slides
Presentation thumbnail
ICARE-TNBC : Immune checkpoint-associated cardiotoxicity risk evaluation in early-stage triple-negative breast cancer
Miss L. Dib (Paris, FR)
Abstract
Presentation thumbnail
Incidence and risk profile of venous thromboembolic events in patients undergoing immune checkpoint inhibitor therapy
Doctor Z. Sandor (Budapest, HU)
Abstract Slides
Presentation thumbnail
Pericoronary fat attenuation on coronary ct identifies persistent vascular inflammation after chest radiotherapy in cancer survivors
Doctor T. De Silva (London, GB)
Abstract Slides
Presentation thumbnail
Optimizing troponin T screening for immune checkpoint inhibitor-associated myocarditis
Mr T. Uyl (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session (1)

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Incidence of cancer treatment-related cardiotoxicity in patients with lymphoma treated with non-pegylated liposomal doxorubicin
21 June 2025
thumbnail
Congress Presentation
Association of inflammatory disease and long-term outcomes among young adults with myocardial infarction: The Partners YOUNG-MI registry
29 August 2020
thumbnail
Congress Presentation
Unrecognized cardiovascular risks in young cervical cancer patients. Findings from the Rebuc study
21 June 2025
thumbnail
Congress Presentation
Machine learning and traditional analysis of the interaction between cardiovascular diseases and hematological malignancies
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources